Main content

Bayer to Cut 12,000 Jobs
Is the pharma giant's model fatally damaged by its acquisition of Monsanto?
The pharmaceutical giant insists the cuts are not prompted by its acquisition of Monsanto nor by a costly California court case over the Roundup weedkiller. Professor Erik Gordon at the University of Michigan says it's a challenging market for big pharmaceuticals in the US. Plus, Cary Leahey from Decision Economics in New York explains how Wall Street reacted to the deliberations of the US Federal Reserve over future interest rates.
Podcast
-
World Business Report
The latest business and finance news from around the world, on the ÃÛÑ¿´«Ã½.